Previous Close | 724.87 |
Open | 723.48 |
Bid | 734.69 x 1000 |
Ask | 735.37 x 1100 |
Day's Range | 721.50 - 737.45 |
52 Week Range | 392.26 - 800.78 |
Volume | |
Avg. Volume | 3,066,637 |
Market Cap | 698.937B |
Beta (5Y Monthly) | 0.37 |
PE Ratio (TTM) | 126.75 |
EPS (TTM) | 5.80 |
Earnings Date | Apr 30, 2024 |
Forward Dividend & Yield | 5.20 (0.72%) |
Ex-Dividend Date | Feb 14, 2024 |
1y Target Est | 826.94 |
ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]